These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15222252)

  • 21. Endothelin as a clinical target in the treatment of systemic hypertension.
    Prasad VS; Palaniswamy C; Frishman WH
    Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
    Pullamsetti SS; Schermuly RT
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis.
    Brunner F; Brás-Silva C; Cerdeira AS; Leite-Moreira AF
    Pharmacol Ther; 2006 Aug; 111(2):508-31. PubMed ID: 16457892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endothelins--their physiological role and their clinical significance].
    Kaletha K; Chodorowski Z; Wyrzykowski B
    Przegl Lek; 1999; 56(12):800-6. PubMed ID: 10789193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin--biology and disease.
    Khimji AK; Rockey DC
    Cell Signal; 2010 Nov; 22(11):1615-25. PubMed ID: 20466059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Sixth International Conference on Endothelin. October 1999, Montreal, Canada.
    Bagnall A; Webb D
    Expert Opin Pharmacother; 2000 Mar; 1(3):575-9. PubMed ID: 11249539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial effects of endothelin-1.
    Brás-Silva C; Leite-Moreira AF
    Rev Port Cardiol; 2008; 27(7-8):925-51. PubMed ID: 18959090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute decompensated heart failure.
    Dec GW
    Curr Probl Cardiol; 2007 Jun; 32(6):321-66. PubMed ID: 17531903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure--new insights.
    Blum A
    Isr Med Assoc J; 2009 Feb; 11(2):105-11. PubMed ID: 19432040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurohormonal inhibition in heart failure: insights from recent clinical trials.
    Gheorghiade M; De Luca L; Bonow RO
    Am J Cardiol; 2005 Dec; 96(12A):3L-9L. PubMed ID: 16399087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of antidiuretic hormone in the pathophysiology and treatment of heart failure.
    Piçarra BC; Dionísio P; Jara A
    Rev Port Cardiol; 2009 Sep; 28(9):971-83. PubMed ID: 19998808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal hemodynamics in heart failure: implications for treatment.
    Rea ME; Dunlap ME
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):87-92. PubMed ID: 18090676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tezosentan in the management of decompensated heart failure.
    Cheng JW
    Cardiol Rev; 2005; 13(1):28-34. PubMed ID: 15596026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
    Teerlink JR; McMurray JJ; Bourge RC; Cleland JG; Cotter G; Jondeau G; Krum H; Metra M; O'Connor CM; Parker JD; Torre-Amione G; Van Veldhuisen DJ; Frey A; Rainisio M; Kobrin I;
    Am Heart J; 2005 Jul; 150(1):46-53. PubMed ID: 16084150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of new agents for acute heart failure syndromes.
    Gheorghiade M; Teerlink JR; Mebazaa A
    Am J Cardiol; 2005 Sep; 96(6A):68G-73G. PubMed ID: 16181825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging diuretics for the treatment of heart failure.
    Sedghi Y; Gaddam KK; Ventura HO
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):195-204. PubMed ID: 19196235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
    Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on endothelins - biology and clinical implications.
    Hunley TE; Kon V
    Pediatr Nephrol; 2001 Sep; 16(9):752-62. PubMed ID: 11511995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?].
    Pérez-Villa F; Roig E; Ferrer E; Cuppoletti A; Llancaqueo M; Jiménez W; Sanz G
    Rev Esp Cardiol; 2004 Aug; 57(8):725-31. PubMed ID: 15282060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.